SCNI

Scinai Immunotherapeutics Ltd.

1.540

-0.900-36.89%

After Hours: 1.430 -0.110 -7.14%19:59 09/15 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.840/2.440

TODAY RANGE1.500-1.880

VOL1.43M

MARKET CAP1.09M

52 WEEK RANGE1.500-16.40

AVG VOL (3M)831.93K

% TURNOVER186.85%

TURNOVER--

P/E (TTM)0.0166

% RANGE15.57%

EPS(TTM)92.72

P/E(FORWARD)-0.7700

P/B0.0075

BVPS205.80

DIVIDEND--

P/S0.0407

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP963.85K

SHARES OUTSTANDING706.59K

NEXT EARNINGS--

FREE FLOAT625.88K

LOT SIZE1

EX-DATE08/21/2026

News

Press Releases

Financial Reports

Profile

TipRanks·09/08 14:30
Scinai Shifts Capital to NanoAb Platform and CDMO Growth After Ending PC111 Deal
TipRanks·09/08 13:25
Scinai Immunotherapeutics refocuses capital on NanoAb platform and CDMO business
PR Newswire·09/08 13:18
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
TipRanks·08/30 00:11
Scinai Immunotherapeutics Earnings Call: Growth vs Liquidity
TipRanks·08/26 12:27
Scinai Highlights First-Half CDMO Expansion and Recipharm Israel Gain in August 2026 Update
NASDAQ·08/24 16:03
Scinai Turns Profit In H1 Amid Shift To CDMO Operations; Stock Down
Seeking Alpha·08/24 11:07
Scinai Immunotherapeutics reports 1H results
PR Newswire·08/24 11:00
Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
TipRanks·08/19 13:47
Scinai Immunotherapeutics Sets 1-for-10 ADS Ratio Change to Support Nasdaq Compliance
TipRanks·08/16 16:22
Upcoming Stock Splits This Week (August 17 to August 21) – What Investors Should Know
TipRanks·06/17 10:31
Scinai Immunotherapeutics Shareholders Approve Board Slate, Equity Expansion and Executive Awards
TipRanks·06/15 11:17
Scinai Immunotherapeutics Boosts CDMO Platform With Recipharm Israel Deal and Q1 2026 Turn to Profit
Seeking Alpha·06/10 20:05
Scinai Immunotherapeutics reports Q1 results
TipRanks·06/08 17:19
Scinai Immunotherapeutics Clarifies Chairman Service Agreement Ahead of June 16 AGM
PR Newswire·05/20 11:00
Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Same Industry

Name/Symbol

Change%

Price

SCNI

REGN

GRDX

BIONTECH

BNTX

+0.34%

96.73

UTHR

Vertex Pharmaceuticals Inc

VRTX

+0.17%

515.44

Siga Technologie

SIGA

+0.33%

3.030

MRNA

Charles Riv Labs Intl Inc

CRL

+1.93%

278.26

MEDP

TLPH

ICON plc

ICLR

+2.18%

169.31

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+1.74%

261.77

MOLN

PRAH

GILD

ARCT

Incyte Corp

INCY

-1.47%

121.47

Aptevo Therapeutics Inc

APVO

-0.55%

1.820

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.